Modulating the ATP-sensitive potassium channels of the beta cell through medical treatment with diazoxide in conjunction with glucagon, octreotide and/or nifedipine are some of the options to inhibit insulin secretion and in turn, control the hypoglycemia [4–9]. The gene discussed is INS; the disease is Hypoglycemia.